Tolerability of carvedilol in heart failure: clinical trials experience
- 1 May 2004
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 93 (9) , 58-63
- https://doi.org/10.1016/j.amjcard.2004.01.027
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Surrogate End Points in Heart FailureAnnals of Pharmacotherapy, 2002
- Neurohormonal blockade in chronic heart failureJournal of the American College of Cardiology, 2001
- Meta-analysis of beta-blockers in heart failure.Int. Journal of Clinical Pharmacology and Therapeutics, 2001
- A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart FailureNew England Journal of Medicine, 2001
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- Chronic heart failure in Australian general practice: The Cardiac Awareness Survey and Evaluation (CASE) StudyThe Medical Journal of Australia, 2001
- Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart FailureJAMA, 2000
- Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL studyJournal of the American College of Cardiology, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996